BioAssay Works (BAW) further enhanced their assay development and manufacturing services capabilities by adding 1,000 square feet of R&D and manufacturing space.

In addition, BAW acquired a new reel-to-reel membrane and gold conjugate ribbon striping machine. “The additional space and new equipment expands our manufacturing capacity significantly”, noted Vice President of Operations, Marc Berman. “It positions us to better serve our customers requiring larger volumes of lateral flow assays. The new equipment allows us to consistently produce lateral flow membranes and gold conjugate ribbons in 100 meter rolls”, described Marc.